Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1960 1
1961 1
1963 2
1964 2
1965 8
1966 3
1967 4
1969 3
1970 2
1971 14
1972 2
1973 3
1974 5
1975 7
1976 3
1977 8
1978 4
1979 7
1980 19
1981 2
1982 6
1983 3
1984 9
1985 4
1986 2
1987 2
1988 2
1990 2
1991 2
1992 4
1993 5
1994 2
1995 3
1996 2
2004 1
2005 2
2007 2
2008 2
2009 6
2010 3
2014 1
2016 1
2019 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth D, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J. Santamaria M, et al. Among authors: hames c. J Clin Immunol. 2022 Apr;42(3):500-511. doi: 10.1007/s10875-021-01181-6. Epub 2022 Jan 1. J Clin Immunol. 2022. PMID: 34973143 Free PMC article.
Hypertension in general practice.
Hames CG. Hames CG. Prev Med. 1974 Sep;3(3):313-22. doi: 10.1016/0091-7435(74)90042-5. Prev Med. 1974. PMID: 4278130 No abstract available.
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth DD, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J. Santamaria M, et al. Among authors: hames c. J Clin Immunol. 2022 Apr;42(3):512-513. doi: 10.1007/s10875-022-01219-3. J Clin Immunol. 2022. PMID: 35174440 Free PMC article. No abstract available.
Nonalcoholic fatty liver disease among HIV-infected persons.
Crum-Cianflone N, Dilay A, Collins G, Asher D, Campin R, Medina S, Goodman Z, Parker R, Lifson A, Capozza T, Bavaro M, Hale B, Hames C. Crum-Cianflone N, et al. Among authors: hames c. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):464-73. doi: 10.1097/QAI.0b013e318198a88a. J Acquir Immune Defic Syndr. 2009. PMID: 19225402 Free PMC article.
Prediagnostic serum selenium and risk of cancer.
Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. Willett WC, et al. Among authors: hames cg. Lancet. 1983 Jul 16;2(8342):130-4. doi: 10.1016/s0140-6736(83)90116-2. Lancet. 1983. PMID: 6134981 Clinical Trial.
168 results